Targeting the non-canonical roles of PCNA modifies and increases the response to targeted anti-cancer therapy
Authors:
Open Access
- 31 December 2019
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 10 (68) , 7185-7197
Abstract
Oncotarget | https://doi.org/10.18632/oncotarget.27267 Caroline K. Søgaard, Anala Nepal, Voin Petrovic, Animesh Sharma, Nina-Beate Liabakk, Tonje S. Steigedal, Marit OtterleiKeywords
This publication has 56 references indexed in Scilit:
- Targeting Proliferating Cell Nuclear Antigen and Its Protein Interactions Induces Apoptosis in Multiple Myeloma CellsPLOS ONE, 2013
- Novel Interaction between Proliferating Cell Nuclear Antigen and HLA I on the Surface of Tumor Cells Inhibits NK Cell Function through NKp44PLOS ONE, 2013
- Combinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer modelsBreast Cancer Research, 2013
- Nucleotide Excision Repair Is Associated with the Replisome and Its Efficiency Depends on a Direct Interaction between XPA and PCNAPLOS ONE, 2012
- Polyubiquitinated PCNA Recruits the ZRANB3 Translocase to Maintain Genomic Integrity after Replication StressMolecular Cell, 2012
- Preview: A Program for Surveying Shotgun Proteomics Tandem Mass Spectrometry DataAnalytical Chemistry, 2011
- Regulating neutrophil apoptosis: new players enter the gameTrends in Immunology, 2011
- EGFR/HER2 inhibitor AEE788 increases ER-mediated transcription in HER2/ER-positive breast cancer cells but functions synergistically with endocrine therapyBritish Journal of Cancer, 2010
- Identification of a novel, widespread, and functionally important PCNA-binding motifJournal of Cell Biology, 2009
- Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cellsBMC Cancer, 2009